Skip to main content
Clinical Trials/NCT06524843
NCT06524843RecruitingNot Applicable

Generation of Synthetic Patient Data (RAW) for Risk Evaluation of Bone Metastases Derived From Carcinoma

Costantino Errani1 site in 1 country250 target enrollmentStarted: September 23, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
250
Locations
1
Primary Endpoint
Creation a dataset of clinical data and diagnostic images

Study Overview

Brief Summary

From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022.

A review will be made from the medical records, radiological imaging, and histological data of these patients

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age ≥ 18 years
  • •Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
  • •Availability of imaging and clinical data
  • •Availability of at least one follow-up during the last 12 months form diagnosis

Exclusion Criteria

  • •At least one inclusion creteria not met

Outcomes

Primary Outcomes

Creation a dataset of clinical data and diagnostic images

Time Frame: At baseline (Day 0)

Creation a dataset of clinical data and diagnostic images, called RAW, relating to patients suffering from metastatic bone cancer that will be used by the unit UNICH to create innovative models for fracture risk prediction and of life expectancy based on various patient clinical parameters.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Costantino Errani
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Costantino Errani

MD

Istituto Ortopedico Rizzoli

Study Sites (1)

Loading locations...

Similar Trials